Skip to content

THIS IS A TEST!!!

Three men of different generations laughing in a garden

DESTIGMATISE

Understanding and Addressing Prostate Cancer Stigma in Black Men

LEAD RESEARCHERS

Olufikayo Bamidele

Dr Olufikayo Bamidele

NIHR Advanced Fellow

TIME FRAME

March 2025 – February 2030

FUNDED BY

The Challenge

Prostate cancer is the most common cancer affecting men in the United Kingdom.

It affects 1 in 4 Black men (men of Black African and Caribbean descent) compared with 1 in 8 White and 1 in 13 Asian men. Early diagnosis enhances men’s survival rates from prostate cancer. However, evidence suggests that self-stigma, public stigma, and structural stigma prevent Black men from talking openly about prostate cancer and from seeking timely help for symptoms, probably due to its association with death and/or lessened masculinity. This causes delays in diagnosis and increased death rates from prostate cancer among Black men. Evidence from wider literature describes stigma as social negative behaviour and/or response towards an individual or a group of people due to their physical, mental, or social attributes, including an illness condition. There is a lack of UK-based research which has specifically sought to understand and address stigma related to prostate cancer among Black men, despite their poorer outcomes from the disease.

"Breaking the shame around prostate cancer isn’t just about awareness—it’s an act of love, a commitment to family and a duty to our community, because no one should suffer in silence when support can save lives."

- Tina Davies OBE, OOR

Siemens

Our aim

Our study aims to understand and address the role of stigma in public health messaging, decision-making and help-seeking for early prostate cancer diagnosis and care among Black men in the United Kingdom.

Our approach

We will collaborate with members of Black communities, NHS providers and wider stakeholders across the UK to conduct the research in four phases.

Phase 1

Interviews, focus groups and surveys with Black men diagnosed with prostate cancer, Black men without prostate cancer and immediate families of Black men with prostate cancer to understand their experiences/perceptions of stigma. By Families, we mean those who may influence men’s decision-making, such as partners.

Phase 2

Stakeholder engagement workshops with Black men and their families to discuss findings from phase one and develop resources which are culturally appropriate with them (such as videos, pocket guides) to inform public health messaging on prostate cancer.

Phase 3

Focus groups with Black men and their families to test if the resources developed are acceptable to them. We will use their comments and feedback to improve the resources so they are useful in clinical and community settings.

Phase 4

Test how practical it will be to integrate the resources within clinical and community settings to improve patient care and early engagement with cancer services among Black men in the UK.

The impact

Beyond seeking to understand an important problem, we will co-develop with Black communities, culturally intelligent solutions to advance equity in experiences and outcomes from prostate cancer among men of Black African and Caribbean descent. This group is disproportionately affected by the illness but underrepresented in research.

Resources from the study will help to advance social discussions on prostate cancer symptoms and potentially encourage Black men to seek help promptly along the entire illness journey - from diagnosis to post-treatment and survivorship. We will make the resources available publicly for individual use and in wider settings including the NHS, community groups, prostate support groups and religious groups.

Patient and public involvement (PPI)

We are committed to involving patients, their families, and local communities within the Black African and Caribbean ethnic groups as active partners in shaping our research. We want to make sure that people with different perspectives and experiences have the chance to influence what we do and how we do it. This helps us to focus on what really matters to members of the Black community in relation to addressing prostate cancer stigma.

We have a dedicated PPI Group who were actively involved in designing the study proposal, developing the study logo, and reviewing the participant-facing documents for the study as part of the ethics application process. The group meets online regularly, providing guidance to ensure the study is culturally sensitive to the needs of the Black communities. They will also help to co-facilitate the stakeholder engagement workshops to develop study outputs and actively involve in recruitment and dissemination activities.

"Losing a family member to prostate cancer hits home. Knowing one in four Black men are at risk, I'm driven to support this vital research. It's about breaking stigma and getting us talking. Because one conversation can make the difference"

- Mr Alston Owens, PPI Member

Research team

Dr Olufikayo Bamidele

NIHR Advanced Fellow

Dr Ireneous Soyiri

Senior Lecturer in Epidemiology

Professor Una Macleod

Professor of Primary Care Medicine

Professor Karl Atkin

Professor of Sociology, University of York

Funding information

Dr Olufikayo Bamidele, Advanced Fellow, NIHR304439 is funded by the NIHR for this research project. The views expressed on this website are those of the author (s) and not necessarily those of the NIHR, NHS or the UK Department of Health and Social Care.

Contact us

Register your interest in this study.

 

To learn more about the study or find out how you can get involved, email destigmatise.study@hyms.ac.uk